DEF: SenesTech Schedules 2026 Annual Meeting, Proposes Director Elections and Equity Plan Amendment

SenesTech, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to elect directors, vote on executive compensation, and approve an amendment to its 2018 Equity Incentive Plan.

Summary

• SenesTech, Inc. is holding its 2026 Annual Meeting of Stockholders on June 9, 2026, at 12:00 p.m. MST in Surprise, Arizona.
• Key agenda items include the election of Jake S. Leach and Joshua M. Moss as Class I directors for three-year terms, a non-binding advisory vote on executive compensation for fiscal year 2025 (say-on-pay), and the approval of an amendment to the 2018 Equity Incentive Plan to increase the number of available shares by 1,700,000.
• The company is also seeking ratification of M&K CPAS, PLLC as its independent registered public accounting firm for fiscal year 2026.
• The record date for determining stockholders entitled to vote is April 20, 2026.
• The company is utilizing a Notice of Internet Availability of Proxy Materials to reduce costs.
• The board of directors has nominated Jake S. Leach and Joshua M. Moss for election as Class I directors.
• The company's 2018 Equity Incentive Plan has limited shares remaining (32,173 as of April 20, 2026), necessitating the proposed amendment to ensure continued ability to attract, motivate, and retain talent.
• If approved, the amendment would increase the total potential dilution from existing equity awards plus shares available for future issuance to approximately 18.9% of fully diluted shares outstanding.
• M&K CPAS, PLLC has served as the company's auditor since December 22, 2014.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, as it addresses necessary corporate governance and talent management needs, but is overshadowed by the company's ongoing net losses and negative stock performance.

Positives

• The proposed amendment to the 2018 Equity Incentive Plan aims to ensure the company can continue to attract, motivate, and retain key talent, which is crucial for executing strategic objectives.
• The company maintains a majority of independent directors on its board, adhering to Nasdaq listing standards.
• The company has a Code of Business Conduct and Ethics and an Executive Officer Clawback Policy in place.
• The company has a policy for reviewing and approving related party transactions, requiring prior consent from the audit committee.
• The company is seeking to increase its equity incentive pool, which is a common and often necessary step for growth-stage companies to remain competitive in talent acquisition and retention.

Negatives

• As of April 20, 2026, only 32,173 shares remain available for future grants under the 2018 Equity Incentive Plan, which is insufficient for the company's ongoing needs.
• The company reported a net loss of $6,383,000 for fiscal year 2025 and $6,184,000 for fiscal year 2024, indicating ongoing profitability challenges.
• Total shareholder return has been negative for the past two fiscal years ($0.58 in 2025 and $0.89 in 2024, based on a $100 investment in 2022).
• No stock option grants were made in 2025 due to insufficient shares available under the 2018 Plan.
• Joel L. Fruendt, the CEO, is retiring and will continue to serve until a successor is appointed or June 30, 2026, indicating a leadership transition.

Risks

• Failure to approve the amendment to the 2018 Equity Incentive Plan could result in the inability to retain management and the Board, requiring reliance on cash compensation which could strain resources and reduce alignment with stockholders.
• The company has experienced net losses in recent fiscal years, indicating financial performance challenges.
• The company's stock performance has been poor, with negative total shareholder returns over the past two fiscal years.
• The proposed increase in shares for the equity incentive plan, if approved, would increase total potential dilution to approximately 18.9% of fully diluted shares outstanding.

Future Outlook

The company is seeking stockholder approval to amend its 2018 Equity Incentive Plan to increase the number of shares available for issuance. This is presented as critical for attracting, motivating, and retaining talent, and for executing commercialization activities. Without this approval, the company anticipates an inability to retain management and the Board, potentially requiring increased cash compensation which could strain resources.

Management Comments

• On behalf of management and our board of directors, we thank you for your continued support and interest in SenesTech, Inc.
• The board of directors believes that a leadership structure that separates the roles of CEO and Chair is appropriate for the company.
• The board of directors believes that the increase in the share reserve is in the best interest of the Company and its stockholders and recommends that stockholders approve the 2018 Amended Plan.

Industry Context

StockSavvy.ai notes that the proposed increase in equity incentive shares is a common strategy for companies, particularly those in growth phases or with limited cash reserves, to remain competitive in attracting and retaining talent. The proposed dilution level of 18.9% is within the median range for similarly situated life science companies, suggesting a standard approach to equity compensation.

Comparison to Industry Standards

• The proposed total potential dilution of 18.9% of fully diluted shares outstanding, if the equity plan amendment is approved, aligns with the median of similarly situated companies, based on data from FW Cook for 35 U.S.-based public life science companies with less than $100 million in market capitalization.
• The company's compensation committee reviews and compares the compensation of other companies in its peer group to set competitive compensation levels.

Management Changes

Corporate Governance

Related Party Transactions

• Consulting fees paid to Hustle and Flower, LLC, founded by director Lynn Y. Graham, for services provided to the Company in 2025 amounted to $24,000.
• The company has adopted a policy requiring audit committee consent for related party transactions exceeding $120,000.

Stakeholder Impact

• Shareholders: Voting on director elections, executive compensation, and equity plan amendments directly impacts their influence and potential dilution. The company's financial performance and stock value are key concerns.
• Employees: The proposed equity plan amendment is intended to ensure continued ability to attract, motivate, and retain employees through equity incentives.
• Management and Directors: The say-on-pay vote and director elections directly involve their compensation and continued service. The CEO's retirement also signifies a leadership change.
• Independent Registered Public Accounting Firm: Stockholder ratification of M&K CPAS, PLLC's appointment ensures continued auditor engagement for fiscal year 2026.

Next Steps

• Stockholders are urged to submit their voting instructions by proxy.
• The company will publish final voting results of the Annual Meeting in a Current Report on Form 8-K within four business days of the meeting.
• If the 2018 Amended Plan is approved, it will become effective as of the date of the Annual Meeting.

Key Dates

Recommendation

The filing is a routine proxy statement for an annual meeting. While it addresses important corporate governance matters like director elections and equity plan amendments necessary for future operations, it does not contain significant new financial information or strategic shifts that would warrant a strong buy or sell recommendation. The company's ongoing net losses and poor stock performance suggest a cautious 'hold' approach pending clearer signs of financial turnaround or strategic success.

Keywords

SenesTech, Proxy Statement, Annual Meeting, Director Election, Equity Incentive Plan, Stockholder Approval, Executive Compensation, Say-on-Pay, Independent Auditor, M&K CPAS, Corporate Governance